Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amiodarone pneumonitis: no safe dose

M I Polkey1, P O Wilson, P J Rees

  • 1Department of Medicine, Guy's Hospital, London, U.K.

Respiratory Medicine
|March 1, 1995
PubMed
Summary

Pneumonitis, a lung inflammation, can occur with amiodarone. This case report details pneumonitis developing after low-dose amiodarone, questioning the safety of such regimens.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physical activity is increased by a 12-week semiautomated telecoaching programme in patients with COPD: a multicentre randomised controlled trial.

Thorax·2017
Same author

Klotho and smoking--An interplay influencing the skeletal muscle function deficits that occur in COPD.

Respiratory medicine·2016
Same author

Request for regulatory guidance for cancer cachexia intervention trials.

Journal of cachexia, sarcopenia and muscle·2015
Same author

Physiological responses to Tai Chi in stable patients with COPD.

Respiratory physiology & neurobiology·2015
Same author

Dynamic laryngeal narrowing in COPD may have effects on the trachea. Response.

Thorax·2015
Same author

Dynamic laryngeal narrowing during exercise: a mechanism for generating intrinsic PEEP in COPD?

Thorax·2015

Area of Science:

  • Cardiology
  • Pulmonology
  • Pharmacology

Background:

  • Amiodarone is an effective antiarrhythmic drug.
  • Pneumonitis is a known serious adverse effect of amiodarone therapy.
  • The risk of amiodarone-induced pneumonitis is generally considered dose-dependent.

Observation:

  • This report describes a case of pneumonitis.
  • The patient developed pneumonitis after exposure to a low daily dose of amiodarone.
  • This contrasts with the established understanding of amiodarone toxicity.

Findings:

  • Low-dose amiodarone therapy may pose a risk for developing pneumonitis.
  • The relationship between amiodarone dosage and pneumonitis requires further investigation.
  • Individual patient susceptibility may play a role in amiodarone-induced lung injury.

Implications:

  • Clinicians should consider the risk of pneumonitis even with low-dose amiodarone.
  • This case challenges the assumption that low-dose amiodarone is inherently safe.
  • Further research is needed to elucidate the mechanisms and risk factors for amiodarone-induced pneumonitis at lower doses.

Related Experiment Videos